Derm News: 2007.10(4)

Long-term clearance of patch-stage mycosis fungoides with the 308-nm laser

Clinical and Experimental Dermatology, 32(2):168-171
E. Upjohn, P. Foley, P. Lane, J. Magee, H. M. Prince, C. McCormack, R. Sinclair
ABSTRACT

Background

In order to investigate the effectiveness of the 308-nm xenon chloride laser in the treatment of patch-stage mycosis fungoides that is refractory to topical steroids, we conducted a prospective, histologically controlled, open-label pilot study. Eight patients with stage 1A or 1B cutaneous T-cell lymphoma that was unresponsive to application of potent topical steroids received 20 treatments with the laser over 10 weeks and were then followed up for a minimum of 30 months.

Three patients had a complete clinical and histological response and remained free of disease after 30 months A further three patients had complete clinical and histological clearance of disease, but experienced relapse within the 30 months follow-up period.

One patient withdrew from the study and one had a partial response. Further research to establish the role of the 308-nm laser in the treatment of MF appears justified.

    Back to Current Volume:   Dermatology News 2007.10

The Derm News service provided by the Editorial Consultants of Skin Therapy Letter^© and its founding editor Dr. Stuart Maddin.